Alpha 2.0
Login Register
» Authors » Kyoko Nagasue

Kyoko Nagasue

Explore the profile of Kyoko Nagasue including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 184
Followers 0
Related Specialties
Nephrology
General Surgery
Top 10 Co-Authors
Senji Okuno
Eiji Ishimura
Yoshiki Nishizawa
Masaaki Inaba
Tetsuo Shoji
Kiyoshi Maekawa
Tomoyuki Yamakawa
Takami Miki
Masao Kim
Yasuo Imanishi
Published In
Am J Kidney Dis
Perit Dial Int
Nephrol Dial Transplant
Nephron Clin Pract
Kidney Int
Affiliations
Soon will be listed here.
Recent Articles
1.
Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism
Ichii M, Ishimura E, Okuno S, Chou H, Kato Y, Tsuboniwa N, et al.
Nephron Clin Pract . 2010 Apr; 115(3):c195-202. PMID: 20413997
Background/aim: Cinacalcet, an allosteric modulator of the calcium-sensing receptor, effectively reduces serum parathyroid hormone (PTH). It was examined whether a regression of parathyroid glands in hemodialysis patients with secondary hyperparathyroidism...
2.
The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis
Yamamoto T, Nagasue K, Okuno S, Yamakawa T
Perit Dial Int . 2010 Mar; 30(3):343-52. PMID: 20338969
Background: Severe peritoneal injury and encapsulating peritoneal sclerosis (EPS) as complications of long-term peritoneal dialysis (PD) are issues of concern. The usefulness of peritoneal lavage after withdrawal of PD and...
3.
FGF-23 in patients with end-stage renal disease on hemodialysis
Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, et al.
Kidney Int . 2004 Apr; 65(5):1943-6. PMID: 15086938
Background: Fibroblast growth factor (FGF)-23 is a recently identified circulating factor which causes renal phosphate wasting disorders. Although the mechanism of regulation of FGF-23 secretion is unknown, plasma FGF-23 level...
4.
Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism
Okuno S, Ishimura E, Kitatani K, Chou H, Nagasue K, Maekawa K, et al.
Nephrol Dial Transplant . 2003 Nov; 18(12):2613-21. PMID: 14605286
Background: Although vitamin D has been reported to be useful in the treatment of patients with secondary hyperparathyroidism, it is not effective in some of them. The goal of this...
5.
Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients
Nishizawa Y, Shoji T, Maekawa K, Nagasue K, Okuno S, Kim M, et al.
Am J Kidney Dis . 2003 Mar; 41(3 Suppl 1):S76-9. PMID: 12612958
Background: Cardiovascular disease is the leading cause of death in patients with end-stage renal disease (ESRD). Previous studies showed that patients with ESRD had increased intima-media thickness of the carotid...
6.
Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients
Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, et al.
Am J Kidney Dis . 2002 Sep; 40(4):802-9. PMID: 12324916
Background: An intact collagen I amino-terminal propeptide (PINP) assay has been developed as a useful assay for bone formation. The present study was performed to investigate the clinical usefulness of...
7.
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus
Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y, et al.
Am J Kidney Dis . 2002 Jun; 39(6):1261-9. PMID: 12046040
Diabetic bone disease is characterized by low bone turnover resulting from either impaired secretion of parathyroid hormone (PTH) or refractoriness of osteoblasts to PTH. The present study was performed to...